Page last updated: 2024-08-23

daunorubicin and Duodenal Diseases

daunorubicin has been researched along with Duodenal Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Enomoto, S; Ishida, Y; Ito, S; Ito, T; Kaneko, J; Kuriya, S; Miyairi, Y; Murai, K; Narigasawa, Y; Numaoka, H; Ono, Y; Shimosegawa, K; Sugawara, T; Utsugisawa, T1

Other Studies

1 other study(ies) available for daunorubicin and Duodenal Diseases

ArticleYear
[Early establishment of bone marrow hypoplasia by antileukemic chemotherapy with concurrent rhG-CSF in a case of acute myelogenous leukemia complicated with intestinal perforation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Duodenal Diseases; Granulocyte Colony-Stimulating Factor; Humans; Intestinal Perforation; Karyotyping; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Recombinant Proteins; Remission Induction

1997